Deakin University
Browse

File(s) under permanent embargo

The predictive impact of MDR1 expression and pre-tumor burden on molecular, cytogenetic and clinical outcome of CML patients on nilotinib therapy after imatinib failure

journal contribution
posted on 2010-06-01, 00:00 authored by M Agrawal, P Erben, B Hanfstein, J Popa, W Hofmann, John Reynolds, L Robin, A Leitner, R Woodman, A Hochhaus, M Müller
The predictive impact of MDR1 expression and pre-tumor burden on molecular, cytogenetic and clinical outcome of CML patients on nilotinib therapy after imatinib failure

History

Journal

Haematologica

Volume

95

Issue

Supp 2

Season

Abstract no.: 0144

Pagination

58 - 59

Publisher

Ferrata Storti Foundation

Location

Pavia, Italy

ISSN

0390-6078

eISSN

1592-8721

Language

eng

Notes

Poster presentation; Abstract book for European Hematology Association. Congress (15th : 2010 : Barcelona,Spain) held from 10 - 13 Jun. 2010

Publication classification

C2.1 Other contribution to refereed journal

Usage metrics

    Research Publications

    Categories

    No categories selected

    Keywords

    predictive impactMDR1 expressionpre-tumor burdenmolecular outcomecytogenetic outcomeclinical outcomechronic myeloid leukaemia (CML) patientsnilotinib therapyimatinib failure

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC